ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Construction of Actively Targeted and High Drug Content Polyprodrug Amphiphiles to Perform Synergistic Chemo-Photo-Anti-Tumor Therapy and Immune-Activated Investigation

Yang, Guangwei; Tao, Longxiang; Kang, Guijie; Yan, Jinhao; He, Kewu*; Wang, Xuefu*; Yin, Jun*安徽医科大学; 1
Chemistry of Materials2023-6-13DOI: 10.1021/acs.chemmater.3c00820
7阅读
引用收藏
分享

摘要

Chemotherapy is one of the most employed strategies inclinicaltreatment of cancer, but the low content of drug molecules causedby the inadequate accumulation of drug carriers in the lesion locationshas an adverse impact on the therapeutic effect. To solve this issue,a kind of high drug content prodrug monomers with topological structuresof AB(2) and AB(3) were designed and utilized toconstruct a series of polyprodrug amphiphiles, P[GMA(-l-RGD/-PEG)-CPT n ] (n =2 or 3), with both targeting peptides (l-RGD) andhigh drug content. Depending on the structure of prodrug monomers,the content of drug molecules could be achieved as high as 60 wt %(n = 2) and 65 wt % (n = 3), respectively.These polyprodrug amphiphiles could self-assemble with photothermalconversion reagents (IR780) in water to form spherical nanoparticles,which could expose original hidden l-RGD throughthe removal of hydrophilic PEG coronas under the trigger of a tumormicroenvironment and thus promote the endocytosis of nanoparticles.Once in the presence of intracellular glutathione (GSH), high contentdrug molecules could be efficiently released by a cascade amplificationreaction to kill cancer cells, this process could be further enhancedby the synergistic effect of local hyperthermia induced by near-infraredlight irradiation. The results from in vitro simulation and in vivomouse solid tumor models showed that these nanoreagents had a highlyinhibitory effect on the tumor. Not only that, the immune responseafter chemical-optical synergistic therapy was also systematicallyconducted, the results demonstrated that the maturation of dendriticcells and proliferation of T cells could be successfully activated,accompanied by the increase of high mobility group protein B1 anddecrease of immunosuppressive regulatory T cells. We believe thisproof-of-concept could effectively solve the bottleneck problem inchemotherapy and provide a continuous immune protection to the bodyafter anti-tumor treatment.

学科与关键词

关键词
TRIGGERED RELEASEDELIVERYNANOPARTICLESACIDNANOMEDICINEGLUTATHIONESTRATEGIESPRODRUG
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Chemistry of Materials
发表日期
2023-06-13
卷期
第 35 卷, 第 12 期
页码
4831-4844
DOI
10.1021/acs.chemmater.3c00820
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Scientific Foundation of China [51973049]; Natural Science Foundation of Anhui Province of China [2108085Y28]; Supporting Program for Outstanding Young Talents in Universities of Anhui Province of China [gxyqZD2021103]; Hefei Independent Innovation Policy Project [J2020Y06]

作者

  • Y

    Yang, Guangwei (第一作者)

  • T

    Tao, Longxiang

    1 · anhui med univ

查看全部 7 位作者收起作者
  • K

    Kang, Guijie

    anhui med univ

  • Y

    Yan, Jinhao

  • H

    He, Kewu (通讯)

    anhui med univ

  • W

    Wang, Xuefu (通讯)

    anhui med univ

  • Y

    Yin, Jun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417